EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Microfluidics for Profiling miRNA Biomarker Panels in AI-Assisted Cancer Diagnosis and Prognosis

Sangeetha Muthamilselvan, Priyannth Ramasami Sundhar Baabu, Ashok Palaniappan iD

Technology in Cancer Research & Treatment · 2023

DOI: 10.1177/15330338231185284 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Technology in Cancer Research & Treatment, 2023. Verfasst von Sangeetha Muthamilselvan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioinformatics, School of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur, Tamil Nadu, India. Hauptthemen laut MEDLINE: MicroRNAs, Neoplasms. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early detection of cancers and their precise subtyping are essential to patient stratification and effective cancer management. Data-driven identification of expression biomarkers coupled with microfluidics-based detection shows promise to revolutionize cancer diagnosis and prognosis. MicroRNAs play key roles in cancers and afford detection in tissue and liquid biopsies. In this review, we focus on the microfluidics-based detection of miRNA biomarkers in AI-based models for early-stage cancer subtyping and prognosis. We describe various subclasses of miRNA biomarkers that could be useful in machine-based predictive modeling of cancer staging and progression. Strategies for optimizing the feature space of miRNA biomarkers are necessary to obtain a robust signature panel. This is followed by a discussion of the issues in model construction and validation towards producing Software-as-Medical-Devices (SaMDs). Microfluidic devices could facilitate the multiplexed detection of miRNA biomarker panels, and an overview of the different strategies for designing such microfluidic systems is presented here, with an outline of the detection principles used and the corresponding performance measures. Microfluidics-based profiling of miRNAs coupled with SaMD represent high-performance point-of-care solutions that would aid clinical decision-making and pave the way for accessible precision personalized medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsNeoplasmsHumansMicrofluidicsBiomarkers, TumorGene Expression ProfilingPrognosisArtificial Intelligence

Stichwörter der Autor:innen

biomarker prioritizationcancer hallmarkscirculating miRNAearly detectionliquid biopsymicrofluidicsmultiplexed detectionprecision medicineprognostic modelsoftware-as-medical-device

Substanzen

MicroRNAsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Bioinformatics, School of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur, Tamil Nadu, India.
  • School of Advanced Materials Science & Engineering, Sungkyunkwan University (SKKU), Suwon, Republic of Korea.

ORCID-Profile: Ashok Palaniappan

Zitieren

APA

Muthamilselvan, S., Ramasami Sundhar Baabu, P., & Palaniappan, A. (2023). Microfluidics for Profiling miRNA Biomarker Panels in AI-Assisted Cancer Diagnosis and Prognosis. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338231185284

Vancouver

Muthamilselvan S, Ramasami Sundhar Baabu P, Palaniappan A. Microfluidics for Profiling miRNA Biomarker Panels in AI-Assisted Cancer Diagnosis and Prognosis. Technology in Cancer Research & Treatment. 2023. doi:10.1177/15330338231185284

BibTeX
@article{Muthamilselvan2023,
  author = {Muthamilselvan, Sangeetha and Ramasami Sundhar Baabu, Priyannth and Palaniappan, Ashok},
  title = {Microfluidics for Profiling miRNA Biomarker Panels in AI-Assisted Cancer Diagnosis and Prognosis},
  journal = {Technology in Cancer Research & Treatment},
  year = {2023},
  doi = {10.1177/15330338231185284}
}
Kostenlos starten →